echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > 4 kinds of medicines including Shufeng Jiedu Capsules in pharmacies were converted to OTC

    4 kinds of medicines including Shufeng Jiedu Capsules in pharmacies were converted to OTC

    • Last Update: 2021-08-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical Network News on July 19, the State Drug Administration issued the "Announcement of the State Drug Administration on the Conversion of Four Drugs including Shufeng Jiedu Capsules to Over-the-Counter Drugs (2021 No.
    90)" (hereinafter referred to as the "Announcement"), It was decided to convert 4 kinds of medicines including Shufeng Jiedu capsules into over-the-counter medicines
    .

    The 4 cold medicines were converted to OTC
    announcements.
    According to the "Administrative Measures for the Classification of Prescription Drugs and Over -the-Counter Drugs (Trial)", the State Drug Administration has organized demonstration and approval, Shufeng Jiedu Capsules, Qingkailing Effervescent Tablets, Huang's Sound Tea The four medicines of Huang's Sound Lozenges were converted from prescription drugs to over-the-counter drugs
    .
    Among the 4 cold medicines, except Qingkailing effervescent tablets, the other 3 varieties are exclusive products
    .
    Among them, Shufeng detoxification capsules Anhui Economy people Pharmaceutical Co.
    , Ltd.
    exclusive products, tea and Huang Huang sound sound tablets exclusively produced by the Wuxi Ji Yu Shan Pharmaceutical Co.
    , Ltd.
    Wo
    .
    Qingkailing effervescent tablets Qing involves two companies , Heilongjiang Dina Pharmaceutical Co.
    , Ltd.
    and Heilongjiang Xiren Pharmaceutical Group Co.
    , Ltd.
    respectively
    .
    The Food and Drug Administration requires that the contents of the non-prescription drug inserts other than those specified in the template inserts shall be implemented in accordance with the original approval documents
    .
    If the drug label involves related content, it should be revised together
    .
    Drugs manufactured since the date of the supplementary application for filing shall not continue to use the original drug inserts
    .
    The prescription drug instructions of double-cross varieties can continue to be used
    .
    According to statistics, with the addition of the 4 varieties this time, as of now, the State Food and Drug Administration has released 13 drugs from prescription drugs to non-prescription drugs in 2021
    .

      Concerned about
    the drugs listed in the OTC catalog for patients with chronic diseases , they are generally low-risk varieties assessed by the China Food and Drug Administration, and consumers can buy with confidence
    .
    The conversion of prescription drugs to OTC means that the promotion model including advertising behavior will change, because the carriers and audiences of prescription drugs and OTC drug advertisements (broadcast) are different, and their consumer groups will also change
    .
    Therefore, this is not only the behavior of pharmaceutical manufacturers, but also involves drug safety issues
    .
    As front-line employees, licensed pharmacists have close contact with patients.
    Therefore, the drugs that have just been "transformed" should be carefully reviewed to observe whether there are adverse reactions, and the patients should be informed of contraindications and precautions in time
    .
    Some experts pointed out that it is not suitable for patients with chronic diseases to choose non-prescription drugs privately, because chronic diseases have complex pathological and physiological changes, and generally require professional doctors to monitor the medication.
    If the condition changes after taking a certain drug for a period of time, it may be this drug The dose should be changed or the drug is no longer applicable and the drug needs to be replaced.
    In this case, the patient cannot judge.
    If you buy OTC drugs by yourself, there may be problems
    .
    The same problem exists for drugs that have just been converted.
    When a licensed pharmacist reviews these drugs that have just been converted, they should also review and manage chronic disease patients and other special populations, and scientifically guide the use of drugs
    .

      Pay attention to the “double-span” status.

    Currently, drug management in China is divided into two categories: prescription drugs and over-the-counter drugs.
    Prescription drugs can only be deployed, purchased, and used with the prescription of a licensed physician or assistant physician.
    Most of the market is limited to hospital terminals.
    , And not to advertise in the mass media
    .
    Over -the-counter drugs are divided into Category A and Category B.
    Category B has a wider range of use than Category A.
    The transfer of prescription drugs to OTC requires a complex process of verification and approval
    .
    Prescription drugs converted to OTC must be prescribed by doctors for long-term clinical practice and adverse reactionsAccording to statistics, the drug regulatory department will evaluate the risk of drugs based on these data, and only drugs with low risk and relatively safe may be converted to OTC
    .
    It is worth noting that the Qingkailing effervescent tablets, Huang's sound tea, and Huang's sound lozenges in this list belong to "double cross"
    .
    The so-called "double-cross drugs" are drugs that have the dual identity of prescription drugs and over-the-counter drugs.
    At present, there are more than 2,000 double-cross drugs in China
    .
    Defining the identity of a "double-cross" drug is mainly based on its indications.
    The common aspirin is a double-cross drug.
    As an over-the-counter drug, its indications are antipyretic, analgesic, and antipyretic.
    It can only be taken for 3 days, and pain can only be used for 5 days.

    .
    When used as a prescription drug, it can be used for rheumatism, rheumatoid arthritis and cardiovascular diseases under the guidance of a doctor.
    It can be taken for a long time
    .
    If it is a prescription drug, the prescription drug leaflet will be included in the package
    .
    If it is "OTC", there will be an "OTC" logo on the medicine box and an over-the-counter drug instruction sheet will be attached
    .
    In recent years, some drugs have also cancelled the double-span category and switched to over-the-counter drugs
    .
    In February 2018, the former State Food and Drug Administration issued the "Announcement of the General Administration on the Conversion of Huoxiang Zhengqi Water and Other Three Drugs to Over-the-Counter Drugs and Revising the OTC Drug Instructions (2018 No.
    15)" The oral liquid and Huoxiangzhengqi soft capsules were abolished from the double-cross category and converted to over-the-counter drugs, and the non-prescription drug instructions of the above three drugs, Huoxiangzhengqi dripping pills and compound fresh bamboo leachate were revised
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.